Program
Please note that this meeting will take place as an in-person event in Toronto and will not live-stream content for virtual participation.
MONDAY, JUNE 21
- Welcome and Keynote lecture
- Plenary Session 1: Harnessing Cancer Evolution for Drug Discovery—Working Group Session
- Poster Session A and Opening Reception
TUESDAY, JUNE 22
- Plenary Session 2: AI and Computational Prediction of Cancer Evolution
- Plenary Session 3: Somatic Evolution in Normal Tissues and Aging
- Proffered talk session
- Plenary Session 4: Premalignant Disease & Cancer Initiation
- Plenary Session 5: Low Disease Burden/MRD/Early Interception
- Poster Session B
WEDNESDAY, JUNE 23
- Plenary Session 6: Metastatic Cascade and Divergent Evolution
- Plenary Session 7: Tumor–Host Crosstalk/Co Evolution
- Plenary Session 8: Treatment Resistance and Evolution Under Therapy
- Closing Remarks
REGISTRATION
3-9 p.m.
WELCOME AND Keynote Lectures
5-6:30 p.m.
- 5:30 p.m. | Welcome by cochairs and introduction of keynote speaker
- 5:35 p.m. | Opening Keynote Lecture
Laura D. Wood, Johns Hopkins University, Baltimore, Maryland
Plenary Session 1: Harnessing Cancer Evolution for Drug Discovery—Working Group Session6:
6:10-7:30 p.m.
Session organized by the Cancer Evolution Working Group
Session Chair: Trevor A. Graham, The Institute of Cancer Research, London, United Kingdom
Poster Session A and Opening Reception
7:30-9 p.m
Continental Breakfast
7-8 a.m.
Plenary Session 2: AI and Computational Prediction of Cancer Evolution
8-9:40 a.m.
Break
9:40 a.m.- 10 a.m.
Plenary Session 3: Somatic Evolution in Normal Tissues and Aging
10 a.m.-11:40 a.m.
Proffered talk session
11:40 a.m.-12:30 p.m.
Lunch on own
12:30 p.m.-2 p.m.
Plenary Session 4: Premalignant Disease and Cancer Initiation
2 p.m.-3:40 p.m.
Break
3:40 – 4 p.m.
Plenary Session 5: The Aging-Inflammation-Cancer Continuum
4-6 p.m.
Poster Session B And Reception
6-7:30 p.m.
Continental Breakfast
7-8 a.m.
Plenary Session 6: Metastatic Cascade and Divergent Evolution
8-9:20 a.m.
Break
9:20-11:45 a.m.
Plenary Session 7:Tumor–Host Crosstalk/Co Evolution
9:45-11:30 a.m.
Break
11:30 -11:45 a.m
Keynote LEcture
11:45 a.m.-12:20 p.m
- Tyler E. Jacks, Massachusetts Institute of Technology, Cambridge, Massachusetts
Plenary Session 8: Treatment Resistance and Evolution Under Therapy
12:20-1:40 p.m.
Closing Remarks and Departure
1:40 p.m.
